Type 2 Diabetes Mellitus with Nephropathy

• CLINICAL_TRIALS trial_result · 2019-10-10
  Clinical Trial Update: Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan [Phase 4]

  Phase 4 clinical study evaluating alfacalcidol in combination with irbesartan for type 2 diabetic nephropathy has completed.

• CLINICAL_TRIALS trial_result · 2019-03-12
  Clinical Trial Update: A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy [Phase 2]

  A Phase 2, placebo-controlled trial evaluating PF-00489791 in patients with type 2 diabetes and overt nephropathy has been completed with re…

• CLINICAL_TRIALS trial_result · 2011-09-08
  Clinical Trial Update: Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy [Phase 4]

  A Phase 4 clinical trial from Shanghai Jiao Tong University School of Medicine is evaluating whether a low-protein diet supplemented with ke…

• CLINICAL_TRIALS trial_result · 2007-11-26
  Clinical Trial Update: Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria [Phase 3]

  This document describes a Phase 3 randomized, double-blind trial comparing APROVEL to placebo in Chinese patients with hypertension and type…

• CLINICAL_TRIALS trial_result · 2007-11-08
  Clinical Trial Update: Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy [Phase 1]

  A Phase 1 trial evaluated the long-term effects of soy consumption on cardio-renal indices and C-reactive protein in individuals with type 2…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.